Company Data
Aptose Biosciences Inc.
Ticker
APS:CA
Current Price
$2.2 -2.65%
Market Cap
$5.6M
Price Target
Refer to Report
Volume
13.3K
52wk Range
$1.02 - $2.59
Overview
Aptose Biosciences Inc is a biotechnology company. It develops targeted medicines and personalized therapies for the precision treatment of life-threatening cancers such as acute myeloid leukemia, myelodysplastic syndromes and other hematologic malignancies and also therapies for Oncology. The firm has CG-806, APTO-253 drugs in preclinical development stage pipeline.